NCT00488878Recruiting
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
Data Collection for Patients With Low Grade Ovarian Carcinoma
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 18 Jun 2007
- Start date
- 19 May 2006
- Primary completion date
- 1 May 2034
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Ovarian cancer, Childhood cancers
- NCT number
- NCT00488878
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 19 May 2006 to the primary completion date, 1 May 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:
- Ovarian tumor of low malignant potential
- Low-grade serous carcinoma of the ovary
- Primary peritoneal tumor of low malignant potential
- Low-grade serous carcinoma of the peritoneum
- Psammocarcinoma
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.